A comparative study on several models of experimental renal calcium oxalate stones formation in rats.
In order to compare the effects of several experimental renal calcium oxalate stones formation models in rats and to find a simple and convenient model with significant effect of calcium oxalate crystals deposition in the kidney, several rat models of renal calcium oxalate stones formation were induced by some crystal-inducing drugs (CID) including ethylene glycol (EG), ammonium chloride (AC), vitamin D(3)[1alpha(OH)VitD(3), alfacalcidol], calcium gluconate, ammonium oxalate, gentamicin sulfate, L-hydroxyproline. The rats were fed with drugs given singly or unitedly. At the end of experiment, 24-h urines were collected and the serum creatinine (Cr), blood urea nitrogen (BUN), the extents of calcium oxalate crystal deposition in the renal tissue, urinary calcium and oxalate excretion were measured. The serum Cr levels in the stone-forming groups were significantly higher than those in the control group except for the group EG+L-hydroxyproline, group calcium gluconate and group oxalate. Blood BUN concentration was significantly higher in rats fed with CID than that in control group except for group EG+L-hydroxyproline and group ammonium oxalate plus calcium gluconate. In the group of rats administered with EG plus Vitamin D(3), the deposition of calcium oxalate crystal in the renal tissue and urinary calcium excretion were significantly greater than other model groups. The effect of the model induced by EG plus AC was similar to that in the group induced by EG plus Vitamin D(3). EG plus Vitamin D(3) or EG plus AC could stably and significantly induced the rat model of renal calcium oxalate stones formation.
Liu
Jihong
J
Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. jhliu@tjh.tjmu.edu.cn
Cao
Zhengguo
Z
Zhang
Zhaohui
Z
Zhou
Siwei
S
Ye
Zhangqun
Z
D000643:Ammonium Chloride / Q000009:adverse effects / Q000378:metabolism / Q000652:urine; D000818:Animals; D001806:Blood Urea Nitrogen; D002118:Calcium / Q000097:blood / Q000378:metabolism / Q000652:urine; D002125:Calcium Gluconate / Q000009:adverse effects / Q000378:metabolism / Q000652:urine; D002129:Calcium Oxalate / Q000378:metabolism / Q000652:urine*; D003404:Creatinine / Q000097:blood; D003460:Crystallization; D004195:Disease Models, Animal; D019855:Ethylene Glycol / Q000009:adverse effects / Q000378:metabolism / Q000652:urine; D005839:Gentamicins / Q000009:adverse effects / Q000378:metabolism / Q000652:urine; D006887:Hydroxycholecalciferols / Q000009:adverse effects / Q000378:metabolism / Q000652:urine; D006909:Hydroxyproline / Q000009:adverse effects / Q000378:metabolism / Q000652:urine; D007668:Kidney / Q000378:metabolism* / Q000473:pathology; D007669:Kidney Calculi / Q000139:chemically induced / Q000378:metabolism* / Q000517:prevention & control; D008274:Magnesium / Q000378:metabolism / Q000652:urine; D008297:Male; D008859:Microscopy, Polarization; D010070:Oxalates / Q000009:adverse effects / Q000378:metabolism / Q000652:urine; D010758:Phosphorus / Q000097:blood; D011897:Random Allocation; D051381:Rats; D017208:Rats, Wistar
D005839:Gentamicins; D006887:Hydroxycholecalciferols; D010070:Oxalates; D000643:Ammonium Chloride; D002129:Calcium Oxalate; D010758:Phosphorus; D003404:Creatinine; D019855:Ethylene Glycol; D008274:Magnesium; D006909:Hydroxyproline; D002125:Calcium Gluconate; D002118:Calcium; C008088:alfacalcidol